Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
Gespeichert in:
| Veröffentlicht in: | Antimicrobial agents and chemotherapy 2010-07, Vol.54 (7), p.3076; author reply 3076-3077 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3077 |
|---|---|
| container_issue | 7 |
| container_start_page | 3076; author reply 3076 |
| container_title | Antimicrobial agents and chemotherapy |
| container_volume | 54 |
| creator | dos Santos, Rodrigo Pires Jacoby, Thalita Goldani, Luciano Zubaran |
| description | |
| doi_str_mv | 10.1128/AAC.00472-10 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2897280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733350907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-7bfcdfc3c757720ca192a52117629207a9227e1723ebf245c554cb177341bdb83</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0Eokvhxhn5xmVTbMeOYw5UqxVfUiU4wNlynMmuUWIHj7OoF347KS0VnDiNZubROx8vIc85u-BctK92u_0FY1KLirMHZMOZaatGmeYh2TDWNJVsmTwjTxC_sTVXhj0mZ4IpJU1jNuTnLpYwBZ9TF9xIscAPl3s8hpmOgJgivqZ9op8Rlj5NKTqscHY5xAN1B4gFtxQXf6QOKeTiZogwbSkMA_gSTjBe0zDNOZ2Ads4XyDdDMmDA4qKHy6fk0eBGhGd38Zx8fff2y_5DdfXp_cf97qrykqtS6W7w_eBrr5XWgnnHjXBKcK4bYQTTzgihgWtRQzcIqfx6nu-41rXkXd-19Tl5c6s7L90EvV83z260cw6Ty9c2uWD_7cRwtId0sqI1WrRsFXh5J5DT9wWw2Cmgh3F0EdKCVsuGN1xJ9X-yrmvFDNMrub0l1-8jZhju9-HM3nhrV2_tb2_Xyoq_-PuGe_iPmfUvuLqiHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733350907</pqid></control><display><type>article</type><title>Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>dos Santos, Rodrigo Pires ; Jacoby, Thalita ; Goldani, Luciano Zubaran</creator><creatorcontrib>dos Santos, Rodrigo Pires ; Jacoby, Thalita ; Goldani, Luciano Zubaran</creatorcontrib><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00472-10</identifier><identifier>PMID: 20554969</identifier><language>eng</language><publisher>United States: American Society for Microbiology (ASM)</publisher><subject>Ampicillin - pharmacology ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Bacteria ; beta-Lactams - pharmacology ; beta-Lactams - therapeutic use ; Carbapenems - pharmacology ; Carbapenems - therapeutic use ; Humans ; Imipenem - pharmacology ; Imipenem - therapeutic use ; Letters to the Editor ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa - drug effects ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - microbiology ; Sulbactam - pharmacology ; Sulbactam - therapeutic use</subject><ispartof>Antimicrobial agents and chemotherapy, 2010-07, Vol.54 (7), p.3076; author reply 3076-3077</ispartof><rights>Copyright © 2010, American Society for Microbiology 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-7bfcdfc3c757720ca192a52117629207a9227e1723ebf245c554cb177341bdb83</citedby><cites>FETCH-LOGICAL-c415t-7bfcdfc3c757720ca192a52117629207a9227e1723ebf245c554cb177341bdb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897280/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897280/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20554969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>dos Santos, Rodrigo Pires</creatorcontrib><creatorcontrib>Jacoby, Thalita</creatorcontrib><creatorcontrib>Goldani, Luciano Zubaran</creatorcontrib><title>Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><subject>Ampicillin - pharmacology</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteria</subject><subject>beta-Lactams - pharmacology</subject><subject>beta-Lactams - therapeutic use</subject><subject>Carbapenems - pharmacology</subject><subject>Carbapenems - therapeutic use</subject><subject>Humans</subject><subject>Imipenem - pharmacology</subject><subject>Imipenem - therapeutic use</subject><subject>Letters to the Editor</subject><subject>Microbial Sensitivity Tests</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Sulbactam - pharmacology</subject><subject>Sulbactam - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0Eokvhxhn5xmVTbMeOYw5UqxVfUiU4wNlynMmuUWIHj7OoF347KS0VnDiNZubROx8vIc85u-BctK92u_0FY1KLirMHZMOZaatGmeYh2TDWNJVsmTwjTxC_sTVXhj0mZ4IpJU1jNuTnLpYwBZ9TF9xIscAPl3s8hpmOgJgivqZ9op8Rlj5NKTqscHY5xAN1B4gFtxQXf6QOKeTiZogwbSkMA_gSTjBe0zDNOZ2Ads4XyDdDMmDA4qKHy6fk0eBGhGd38Zx8fff2y_5DdfXp_cf97qrykqtS6W7w_eBrr5XWgnnHjXBKcK4bYQTTzgihgWtRQzcIqfx6nu-41rXkXd-19Tl5c6s7L90EvV83z260cw6Ty9c2uWD_7cRwtId0sqI1WrRsFXh5J5DT9wWw2Cmgh3F0EdKCVsuGN1xJ9X-yrmvFDNMrub0l1-8jZhju9-HM3nhrV2_tb2_Xyoq_-PuGe_iPmfUvuLqiHw</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>dos Santos, Rodrigo Pires</creator><creator>Jacoby, Thalita</creator><creator>Goldani, Luciano Zubaran</creator><general>American Society for Microbiology (ASM)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20100701</creationdate><title>Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?</title><author>dos Santos, Rodrigo Pires ; Jacoby, Thalita ; Goldani, Luciano Zubaran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-7bfcdfc3c757720ca192a52117629207a9227e1723ebf245c554cb177341bdb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Ampicillin - pharmacology</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteria</topic><topic>beta-Lactams - pharmacology</topic><topic>beta-Lactams - therapeutic use</topic><topic>Carbapenems - pharmacology</topic><topic>Carbapenems - therapeutic use</topic><topic>Humans</topic><topic>Imipenem - pharmacology</topic><topic>Imipenem - therapeutic use</topic><topic>Letters to the Editor</topic><topic>Microbial Sensitivity Tests</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Sulbactam - pharmacology</topic><topic>Sulbactam - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>dos Santos, Rodrigo Pires</creatorcontrib><creatorcontrib>Jacoby, Thalita</creatorcontrib><creatorcontrib>Goldani, Luciano Zubaran</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>dos Santos, Rodrigo Pires</au><au>Jacoby, Thalita</au><au>Goldani, Luciano Zubaran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>54</volume><issue>7</issue><spage>3076; author reply 3076</spage><epage>3077</epage><pages>3076; author reply 3076-3077</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><cop>United States</cop><pub>American Society for Microbiology (ASM)</pub><pmid>20554969</pmid><doi>10.1128/AAC.00472-10</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial agents and chemotherapy, 2010-07, Vol.54 (7), p.3076; author reply 3076-3077 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2897280 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Ampicillin - pharmacology Ampicillin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Bacteria beta-Lactams - pharmacology beta-Lactams - therapeutic use Carbapenems - pharmacology Carbapenems - therapeutic use Humans Imipenem - pharmacology Imipenem - therapeutic use Letters to the Editor Microbial Sensitivity Tests Pseudomonas aeruginosa - drug effects Pseudomonas Infections - drug therapy Pseudomonas Infections - microbiology Sulbactam - pharmacology Sulbactam - therapeutic use |
| title | Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A20%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20stewardship%20lessons:%20do%20Pseudomonas-sparing%20agents,%20such%20as%20ertapenem,%20effectively%20improve%20bacterial%20resistance?&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=dos%20Santos,%20Rodrigo%20Pires&rft.date=2010-07-01&rft.volume=54&rft.issue=7&rft.spage=3076;%20author%20reply%203076&rft.epage=3077&rft.pages=3076;%20author%20reply%203076-3077&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.00472-10&rft_dat=%3Cproquest_pubme%3E733350907%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733350907&rft_id=info:pmid/20554969&rfr_iscdi=true |